Trevi Therapeutics News

Trevi Therapeutics | 8-K: Trevi Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Updates Reaffirming Clinical Trial Guidance

Aug 8 16:17 ET

Trevi Therapeutics | 8-K: Current report

Jun 13 17:05 ET

Trevi Therapeutics | 8-K: Trevi Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates

May 7 16:11 ET

Trevi Therapeutics | DEFA14A: Others

Apr 26 16:50 ET

Trevi Therapeutics | DEF 14A: Definitive information statements

Apr 26 16:45 ET

Trevi Therapeutics | 8-K: Trevi Therapeutics Reports Fourth Quarter and Year End 2023 Financial Results and Provides Business Updates

Mar 20 16:16 ET

Trevi Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Mar 20 16:13 ET

Trevi Therapeutics | 8-K: Trevi Therapeutics Announces Third Quarter 2023 Financial Results and Provides Business Update

Nov 9, 2023 16:08 ET

Trevi Therapeutics | S-3/A: Registration statement for specified transactions by certain issuers (Amendment)

Aug 11, 2023 16:06 ET

Trevi Therapeutics | 8-K: Trevi Therapeutics Announces Second Quarter 2023 Financial Results and Provides Business Update

Aug 10, 2023 16:08 ET

Trevi Therapeutics | S-3: Registration statement for specified transactions by certain issuers

Jun 29, 2023 17:06 ET

Trevi Therapeutics | 8-K: Current report

Jun 29, 2023 16:02 ET

Trevi Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

May 11, 2023 16:16 ET

Trevi Therapeutics | 8-K: Trevi Therapeutics Announces First Quarter 2023 Financial Results and Provides Business Update

May 11, 2023 16:09 ET

Trevi Therapeutics | DEFA14A: Others

May 1, 2023 16:03 ET

Trevi Therapeutics | DEF 14A: Definitive proxy statements

May 1, 2023 16:02 ET

Trevi Therapeutics | PRE 14A: Preliminary proxy statement not related to a contested matter or merger/acquisition

Apr 14, 2023 16:26 ET

Trevi Therapeutics | 8-K: Current report

Apr 14, 2023 16:01 ET

Trevi Therapeutics | 8-K: Trevi Therapeutics Announces Fourth Quarter and Year End 2022 Financial Results and Provides Business Update

Mar 16, 2023 16:11 ET

Trevi Therapeutics | 8-K: Trevi Therapeutics Announces Third Quarter 2022 Financial Results and Provides Business Update

Nov 10, 2022 16:08 ET